News
-
May 13th 2021 - Press notes
The Urology and Nuclear Medicine and Radiology services at the centre are collaborating with the British company Lightpoint Medical to develop new equipment that will improve the detection of the sentinel lymph node in prostate cancer patients. Hospital del Mar is coordinating the international clinical trial to validate its usefulness. Hospitals from Germany, France, the United Kingdom, the Netherlands and Belgium are participating. The centre is a Spanish leader in the use of the prostate sentinel node technique. This involves injecting the tumour with a marker that drains through the lymph ducts and allows the first tumour drainage node to be detected. Thanks to this technique, the treatment can be personalised and it is possible to identify more precisely whether the nodes are affected.
more information
-
April 29th, 2021 - Press notes
The benchmark meeting in the field of immunotherapy cancer treatment was held once again, on April 9, in a hybrid format. This year, the presentations focused on the research and development of this type of treatment for various types of tumours, as well as molecular diagnostics.
more information
-
April 22nd - Press notes
Dr. Anna Bigas, coordinator of the Stem cells and cancer Research Group of the Hospital del Mar Medical Research Institute (IMIM) and scientific director of the CIBER Oncology has been chosen one of the Top 100 Women Leaders in Spain.
more information
-
14 April 2021 - Press notes
Awareness of this fact may provide anaesthesiologists with increased control over the procedure, allow them to carry it out more safely and allow for more accurate dosage of anaesthetics. The study, which has been published by the journal Sleep, was carried out with healthy volunteers who underwent neuroimaging tests to assess the brain's reaction during the anaesthetic procedure. Researchers have been able to determine the exact moment in which the cerebral cortex and brain stem go out of sync, namely, when loss of consciousness is achieved.
more information
-
8th April 2021 - Press notes
The bachelor's degree will have a new syllabus, fully adapted to the needs of medicine today and in the future that will involve a change in the methods and approach of teaching, with a clear clinical leaning due to its integration with Hospital del Mar. One of the distinguishing features of the bachelor's degree in Medicine is its location in a unique bio-health environment, formed by the Mar University Campus, Hospital del Mar and the Barcelona Biomedical Research Park. Aspects of current medicine will be the focus, such as cancer, infectious diseases, care for the critically ill, personalized and precision medicine, systems medicine and telemedicine.
more information
-
9th March 2021 - Press notes
Family members of patients who follow an intensive weight loss programme, planned within the PREDIMED study, also lose weight and improve their commitment to the Mediterranean diet. Despite not participating in the programme, these people had lost an average of almost four kilos, two years after their family member started the programme. This was particularly true in cases where they shared meals and the patient did the cooking. The same contagion effect was not observed with regard to physical activity among patients and their families. The patients also experienced improved weight loss, of almost seven kilos over the same period. The results of the study have been published in the International Journal of Obesity.
more information
-
March 3rd, 2021 - Press notes
Article published in Nutrients
A study by physicians and researchers at Hospital del Mar, the Hospital del Mar Medical Research Institute and Pompeu Fabra University has shown that patients infected with SARS-CoV-2 coronavirus with lower blood zinc levels require a longer recovery time and are at higher risk of death. Mortality in this patient group was 21% compared to 5% of those with higher levels of zinc in the blood. At the same time, the study has carried out in vitro tests which demonstrated the protective effect of this element by limiting the spread of the coronavirus in human cells. The researchers draw attention to the benefits of zinc supplementation for patients with covid-19 to speed up their recovery and to risk groups to limit the severity of its effects. The study has just been published in the journal Nutrients and was one of the highlights of the European Society of Clinical Microbiology and Infectious Diseases' conference on covid-19.
more information
-
12th February 2021 - Press notes
The Hospital del Mar is the promoter of the Phase 2 study that will assess the antiviral efficacy of compound E-52862, produced by ESTEVE, in the early treatment of outpatients with mild COVID-19 symptoms.
more information
-
2 February, 2021 - Press notes
The worsened mental health and mood of elderly people at risk of developing dementia, caused by the lockdown measures, was prolonged during the early weeks of de-escalation. The study, led by researchers from the Hospital del Mar Medical Research Institute and doctors from Hospital del Mar, in collaboration with the Barcelona βeta Brain Research Center, a research centre affiliated with the Pasqual Maragall Foundation, has been published in the Journal of Alzheimer's Disease. New technologies were used to monitor the participants and understand the impact of lockdown. The people who took part are part of the PIENSA study on the prevention of cognitive deterioration in stages prior to the onset of dementia.
more information
-
16 December 2020 - Press notes
This work is a collaboration between Núria López-Bigas' lab at IRB Barcelona and the groups headed by Anna Bigas (Hospital del Mar Medical Research Institute) and Josep Maria Ribera (Josep Carreras Leukaemia Research Institute). The results have been published in Genome Biology.
more information